Skip to Main Content

Paper Details

Single-arm clinical trials that supported FDA accelerated approvals have modest effect sizes and were at high risk of bias.
J Clin Epidemiol
6
2022
Author NameAffiliation
Charles L BennettBeckman Research Institute, Center for Medication Safety and Efficacy, University of South Carolina College of Pharmacy
Charles L BennettBeckman Research Institute, Center for Medication Safety and Efficacy, University of South Carolina College of Pharmacy
Benjamin DjulbegovicBeckman Research Institute
  • 1 - 3

Datasets

Release 1.2